Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
According to Novartis's latest financial reports and stock price the company's current Operating Margin is 16.15%. At the end of 2021 the company had an Operating Margin of 49.43%.
Year | Operating Margin | Change |
---|---|---|
2021 | 49.43% | 149.69% |
2020 | 19.80% | 7.79% |
2019 | 18.37% | -29.42% |
2018 | 26.02% | 44.97% |
2017 | 17.95% | 13.52% |
2016 | 15.81% | -2.05% |
2015 | 16.14% | -29.45% |
2014 | 22.88% | 25.39% |
2013 | 18.25% | -6.58% |
2012 | 19.53% | 7.65% |
2011 | 18.14% | -20.05% |
2010 | 22.70% | 3.17% |
2009 | 22.00% | -1.38% |
2008 | 22.31% | 16.04% |
2007 | 19.22% | -14.9% |
2006 | 22.59% | 1.13% |
2005 | 22.34% | -8.67% |
2004 | 24.46% | 0.21% |
2003 | 24.40% | -10.16% |
2002 | 27.17% | 2.83% |
2001 | 26.42% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 24.28% | 50.34% | ๐บ๐ธ USA |
![]() Pfizer PFE | 29.90% | 85.14% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | 19.02% | 17.77% | ๐บ๐ธ USA |
![]() Sanofi SNY | 19.90% | 23.22% | ๐ซ๐ท France |
![]() Merck MRK | 28.49% | 76.41% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 16.70% | 3.41% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | -0.70% | -104.33% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | 19.52% | 20.87% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | 4.14% | -74.37% | ๐ฎ๐ฑ Israel |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.